Elsevier

Annals of Oncology

Volume 31, Supplement 4, September 2020, Pages S1101-S1102
Annals of Oncology

1955P Survival benefits of larotrectinib in an integrated dataset of patients with TRK fusion cancer

https://doi.org/10.1016/j.annonc.2020.08.1347Get rights and content
Under an Elsevier user license
open archive

Cited by (0)